{
    "Trade/Device Name(s)": [
        "Atellica IM Ferritin Assay",
        "Atellica IM Ferritin (Fer) Assay"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K171642",
    "Predicate Device Reference 510(k) Number(s)": [
        "K992157",
        "K041133"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DBF"
    ],
    "Summary Letter Date": "May 31, 2017",
    "Summary Letter Received Date": "June 2, 2017",
    "Submission Date": "August 24, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.5340"
    ],
    "Regulation Name(s)": [
        "Ferritin immunological test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "immunology"
    ],
    "Analyte(s)": [
        "Ferritin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "EDTA Plasma",
        "Lithium Heparin Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Atellica IM Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Sandwich immunoassay",
        "Chemiluminescence",
        "Direct chemiluminometric technology"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Atellica IM Ferritin assay measuring ferritin in human serum and plasma via chemiluminescent sandwich immunoassay on Atellica IM Analyzer",
    "Indications for Use Summary": "For in vitro diagnostic use in the quantitative determination of ferritin in human serum and plasma (EDTA and lithium heparin) as an aid in the diagnosis of iron deficiency anemia and iron overload",
    "fda_folder": "Immunology"
}